SCHEMBL10028189

SCHEMBL10028189

c1cc2ccc3oc4cc(-c5cc6ccc7oc8cccc9ccc%10oc(c5)c6c7-c%10c98)cc5ccc6oc(c1)c2c3-c6c54

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.36
CYP1A1 P04798 3/20 0.36
CYP1B1 Q16678 2/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
AHR P35869 4/20 0.33
FYN P06241 2/20 0.32
MAOA P21397 2/20 0.32
ERBB2 P04626 1/20 0.32
ACHE P22303 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
ABCG2 Q9UNQ0 2/20 0.32
MAPK3 P27361 1/20 0.32
PAX8 Q06710 1/20 0.32
PGR P06401 2/20 0.32
CA12 O43570 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10028190 0.96 PGR (0.37) CYP1A2CYP1A1CYP1B1ALDH1A1HPGD
SCHEMBL10028203 0.89 CYP1A2 (0.39) CYP1A2CYP1A1ALDH1A1HPGDHSD17B10
SCHEMBL10028197 0.87 AHR (0.38) CYP1A2CYP1A1ALDH1A1HPGDHSD17B10
SCHEMBL29737512 0.86 ALDH1A1 (0.48) CYP1A2CYP1A1CYP1B1ALDH1A1HPGD
SCHEMBL10028079 0.86 ALDH1A1 (0.48) CYP1A2CYP1A1CYP1B1ALDH1A1HPGD
SCHEMBL10028085 0.86 ESR1 (0.43) CYP1A2ALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL10028087 0.85 PGR (0.46) CYP1A2CYP1A1ALDH1A1HPGDAHR
SCHEMBL14307843 0.83 CYP11B1 (0.30) HSD17B10CYP3A4TSHRLMNA
SCHEMBL17304507 0.82 ALDH1A1 (0.36) CYP1A2CYP1A1CYP1B1ALDH1A1HPGD
SCHEMBL10028191 0.81 NPC1 (0.33) CYP1A2CYP1A1CYP1B1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2046915-B1 NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2015-12-02 EP disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-8114531-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2012-02-14 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100013381-A1 NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES L1CAM, SOD1, SLC40A1 CYP1A2 1150/4885CYP1A1 751/4885CYP1B1 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.